Charles Homcy
Chairman
BridgeBio Pharma, Inc. (BBIO)Board Member
BridgeBio Pharma, Inc. (BBIO)Board Member
Maze Therapeutics, Inc. (MAZE)Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Pharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBIO alertsAbout Charles Homcy
Charles Homcy is recorded as Chairman and Board Member at BridgeBio Pharma, Inc. (BBIO) and Board Member at Maze Therapeutics, Inc. (MAZE) since January 1, 2018. The newest filing on record that lists Charles Homcy as Board Member at BridgeBio Pharma, Inc. (BBIO) is dated April 24, 2026. The newest filing on record that lists Charles Homcy as Chairman at BridgeBio Pharma, Inc. (BBIO) is dated April 30, 2021. The proxy statement of BridgeBio Pharma, Inc. reports total compensation of $1,855,805 for Charles Homcy in fiscal 2020, including a base salary of $500,000. Disclosed compensation is on record for 2 fiscal years. BridgeBio Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Maze Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Pharma, Inc. includes Neil Kumar (CEO and Board Member), Brian Stephenson (CFO), Thomas Trimarchi (CFO and COO) and 7 others.
Affiliation history
-
Current
2018-01-01–present
Last confirmed April 28, 2026
-
Current
Start not stated–present
Last confirmed April 30, 2021
-
Current
Start not stated–present
Last confirmed April 24, 2026
Company network
Biotechnology · Healthcare
Board Member
2018-01-01–present
Leadership on record at BridgeBio Pharma, Inc.
- Neil Kumar CEO, Board Member
- Brian Stephenson CFO
- Thomas Trimarchi CFO, COO
- Brian Stolz COO
- Brian C. Stephenson Chief Accounting Officer
- Ali J. Satvat Board Member
- Andrea Ellis Board Member
- Andrea J. Ellis Board Member
- Andrew W. Lo Board Member
- Douglas A. Dachille Board Member
Leadership on record at Maze Therapeutics, Inc.
- Jason Coloma CEO, Board Member
- Hervé Hoppenot Chairman, Board Member
- Misbah Tahir CFO
- Courtney Phillips General Counsel
- Continuing Directors Board Member
- Daniel Spiegelman Board Member
- Jonathan Lim Board Member
- Nancy C. Andrews, M.D., Ph.D. Board Member
- Neil Kumar Board Member
- Paula A. Johnson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | BridgeBio Pharma, Inc. (BBIO) | Chairman of Pharmaceuticals | $500,000 | $1,855,805 |
| 2019 | BridgeBio Pharma, Inc. (BBIO) | Chairman of Pharmaceuticals | $513,808 | $5,975,842 |
Recent activity
No call appearances or filed executive changes recorded yet.